The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 825 | 36,733 | SH | SOLE | 36,733 | 0 | 0 | ||
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 359 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 1,309 | 16,002 | SH | SOLE | 16,002 | 0 | 0 | ||
AKEBIA THERAPEUTICS INC | COM | 00972D105 | 477 | 50,004 | SH | SOLE | 50,004 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 1,544 | 13,853 | SH | SOLE | 13,853 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 1,410 | 24,333 | SH | SOLE | 24,333 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 1,629 | 13,680 | SH | SOLE | 13,680 | 0 | 0 | ||
AMGEN INC | COM | 031162100 | 990 | 5,805 | SH | SOLE | 5,805 | 0 | 0 | ||
AVEXIS INC | COM | 05366U100 | 281 | 2,275 | SH | SOLE | 2,275 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 327 | 133,500 | SH | SOLE | 133,500 | 0 | 0 | ||
BIO TECHNE CORP | COM | 09073M104 | 303 | 2,009 | SH | SOLE | 2,009 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 963 | 3,517 | SH | SOLE | 3,517 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 864 | 10,656 | SH | SOLE | 10,656 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 226 | 1,326 | SH | SOLE | 1,326 | 0 | 0 | ||
CELGENE CORP | COM | 151020104 | 849 | 9,512 | SH | SOLE | 9,512 | 0 | 0 | ||
CHARLES RIV LABS INTL INC | COM | 159864107 | 279 | 2,613 | SH | SOLE | 2,613 | 0 | 0 | ||
CHECKPOINT THERAPEUTICS INC | COM | 162828107 | 495 | 112,760 | SH | SOLE | 112,760 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 686 | 13,000 | SH | SOLE | 13,000 | 0 | 0 | ||
CONTRAFECT CORP | COM | 212326102 | 122 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 845 | 18,281 | SH | SOLE | 18,281 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 276 | 3,667 | SH | SOLE | 3,667 | 0 | 0 | ||
GRIFOLS S A | SP ADR REP B NVT | 398438408 | 285 | 13,422 | SH | SOLE | 13,422 | 0 | 0 | ||
ILLUMINA INC | COM | 452327109 | 1,302 | 5,506 | SH | SOLE | 5,506 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 940 | 11,278 | SH | SOLE | 11,278 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 277 | 4,496 | SH | SOLE | 4,496 | 0 | 0 | ||
INTREXON CORP | COM | 46122T102 | 283 | 18,478 | SH | SOLE | 18,478 | 0 | 0 | ||
IONIS PHARMACEUTICALS INC | COM | 462222100 | 1,020 | 23,133 | SH | SOLE | 23,133 | 0 | 0 | ||
IQVIA HLDGS INC | COM | 46266C105 | 283 | 2,889 | SH | SOLE | 2,889 | 0 | 0 | ||
ISHARES TR | NASDAQ BIOTECH | 464287556 | 2,001 | 18,750 | SH | SOLE | 18,750 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 671 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
LOXO ONCOLOGY INC | COM | 548862101 | 796 | 6,900 | SH | SOLE | 6,900 | 0 | 0 | ||
MEDICINES CO | COM | 584688105 | 231 | 7,000 | SH | SOLE | 7,000 | 0 | 0 | ||
METTLER TOLEDO INTERNATIONAL | COM | 592688105 | 2,067 | 3,594 | SH | SOLE | 3,594 | 0 | 0 | ||
NEKTAR THERAPEUTICS | COM | 640268108 | 2,490 | 23,431 | SH | SOLE | 23,431 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 268 | 3,232 | SH | SOLE | 3,232 | 0 | 0 | ||
PACIRA PHARMACEUTICALS INC | COM | 695127100 | 389 | 12,500 | SH | SOLE | 12,500 | 0 | 0 | ||
PARATEK PHARMACEUTICALS INC | COM | 699374302 | 260 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
PROGENICS PHARMACEUTICALS IN | COM | 743187106 | 81 | 10,891 | SH | SOLE | 10,891 | 0 | 0 | ||
PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 473 | 153,846 | SH | SOLE | 153,846 | 0 | 0 | ||
PROSHARES TR | PSHS ULT NASB | 74347R214 | 10,330 | 187,610 | SH | SOLE | 187,610 | 0 | 0 | ||
PROSHARES TR | PSHS ULT NASB | 74347R214 | 3,304 | 60,000 | SH | Put | SOLE | 60,000 | 0 | 0 | |
QIAGEN NV | SHS NEW | N72482123 | 1,072 | 33,165 | SH | SOLE | 33,165 | 0 | 0 | ||
RECRO PHARMA INC | COM | 75629F109 | 139 | 12,615 | SH | SOLE | 12,615 | 0 | 0 | ||
REGENERON PHARMACEUTICALS | COM | 75886F107 | 903 | 2,622 | SH | SOLE | 2,622 | 0 | 0 | ||
SCYNEXIS INC | COM | 811292101 | 45 | 33,304 | SH | SOLE | 33,304 | 0 | 0 | ||
SEATTLE GENETICS INC | COM | 812578102 | 1,106 | 21,126 | SH | SOLE | 21,126 | 0 | 0 | ||
SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 2,088 | 23,800 | SH | SOLE | 23,800 | 0 | 0 | ||
TESARO INC | COM | 881569107 | 657 | 11,500 | SH | SOLE | 11,500 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 372 | 7,291 | SH | SOLE | 7,291 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 290 | 2,579 | SH | SOLE | 2,579 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 1,503 | 9,224 | SH | SOLE | 9,224 | 0 | 0 |